Literature DB >> 22436565

Development of the motivational system during adolescence, and its sensitivity to disruption by nicotine.

Danielle S Counotte1, August B Smit, Tommy Pattij, Sabine Spijker.   

Abstract

The brain continues to develop during adolescence, and exposure to exogenous substances such as nicotine can exert long-lasting adaptations during this vulnerable period. In order to fully understand how nicotine affects the adolescent brain it is important to understand normal adolescent brain development. This review summarizes human and animal data on brain development, with emphasis on the prefrontal cortex, for its important function in executive control over behavior. Moreover, we discuss how nicotine exposure during adolescence can disrupt brain development bearing long-term consequences on executive cognitive function in adulthood.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22436565     DOI： 10.1016/j.dcn.2011.05.010

Source DB:  PubMed          Journal:  Dev Cogn Neurosci        ISSN： 1878-9293            Impact factor:   6.464


  37 in total

1.  Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.

Authors:  David A Connor; Thomas J Gould
Journal:  Neuropharmacology       Date:  2017-08-02       Impact factor: 5.250

2.  Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex.

Authors:  Danielle S Counotte; Natalia A Goriounova; Milena Moretti; Marek T Smoluch; Hubertus Irth; Francesco Clementi; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Cecilia Gotti; Sabine Spijker
Journal:  FASEB J       Date:  2012-02-03       Impact factor: 5.191

3.  Psychiatric comorbidity in adolescent electronic and conventional cigarette use.

Authors:  Adam M Leventhal; David R Strong; Steve Sussman; Matthew G Kirkpatrick; Jennifer B Unger; Jessica L Barrington-Trimis; Janet Audrain-McGovern
Journal:  J Psychiatr Res       Date:  2015-11-22       Impact factor: 4.791

4.  E-cigarettes: Are we renormalizing public smoking? Reversing five decades of tobacco control and revitalizing nicotine dependency in children and youth in Canada.

Authors:  Richard Stanwick
Journal:  Paediatr Child Health       Date:  2015-03       Impact factor: 2.253

5.  Impulsivity and cigarette craving among adolescent daily and occasional smokers.

Authors:  Amanda R Mathew; Jessica L Burris; Brett Froeliger; Michael E Saladin; Matthew J Carpenter
Journal:  Addict Behav       Date:  2015-01-30       Impact factor: 3.913

Review 6.  On the interaction between drugs of abuse and adolescent social behavior.

Authors:  Viviana Trezza; Petra J J Baarendse; Louk J M J Vanderschuren
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

7.  Long-term effects of chronic nicotine on emotional and cognitive behaviors and hippocampus cell morphology in mice: comparisons of adult and adolescent nicotine exposure.

Authors:  Erica D Holliday; Paul Nucero; Munir G Kutlu; Chicora Oliver; Krista L Connelly; Thomas J Gould; Ellen M Unterwald
Journal:  Eur J Neurosci       Date:  2016-10-19       Impact factor: 3.386

8.  Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence.

Authors:  Adam M Leventhal; David R Strong; Matthew G Kirkpatrick; Jennifer B Unger; Steve Sussman; Nathaniel R Riggs; Matthew D Stone; Rubin Khoddam; Jonathan M Samet; Janet Audrain-McGovern
Journal:  JAMA       Date:  2015-08-18       Impact factor: 56.272

9.  Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

Authors:  S S Somkuwar; K M Kantak; M T Bardo; L P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2015-12-02       Impact factor: 3.533

Review 10.  Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.

Authors:  Eric C Donny; Dorothy K Hatsukami; Neal L Benowitz; Alan F Sved; Jennifer W Tidey; Rachel N Cassidy
Journal:  Prev Med       Date:  2014-06-23       Impact factor: 4.018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.